Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts
NCT ID: NCT00657462
Last Updated: 2017-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14122 participants
INTERVENTIONAL
2008-04-30
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MobileMedMinder: A Networked Aide for Medication Compliances
NCT01597583
A Mobile Phone Based Medication Reminder Program
NCT02793830
Electronic Medical Record Reminders and Panel Management to Improve Primary Care of Elderly Patients
NCT01313169
Improving Quality With Outpatient Decision Support
NCT00225628
ARemind: A Personalized System to Remind for Adherence
NCT01229722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. copying the pre-admission medication list (PAML) to the clipboard
2. viewing the detailed audit trail of all changes made to the PAML
3. sorting the list of medications obtained from other electronic sources by therapeutic class.
Reminder prompts (sometimes referred to as "Tip of the Day") have been employed to increase user awareness of underutilized application features. However, anecdotally some users find them unhelpful and potentially irritating. It is therefore important to determine whether reminder prompts accomplish the stated task of increasing application feature utilization. This project will compare PAML Builder application feature utilization before and after a pilot rollout of reminder prompts to determine whether they should be implemented permanently.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Receives the intervention (reminders displayed at the startup of the application) for both periods (period 1 and period 2) of the study.
Reminders
Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application
B
Receives the intervention (reminders displayed at the application startup) only during the second period (period 2) of the study.
Reminders
Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reminders
Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexander Turchin
Senior Medical Informatician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Turchin, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Partners HealthCare
Carol Broverman, PhD
Role: PRINCIPAL_INVESTIGATOR
Partners HealthCare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Poon EG, Blumenfeld B, Hamann C, Turchin A, Graydon-Baker E, McCarthy PC, Poikonen J, Mar P, Schnipper JL, Hallisey RK, Smith S, McCormack C, Paterno M, Coley CM, Karson A, Chueh HC, Van Putten C, Millar SG, Clapp M, Bhan I, Meyer GS, Gandhi TK, Broverman CA. Design and implementation of an application and associated services to support interdisciplinary medication reconciliation efforts at an integrated healthcare delivery network. J Am Med Inform Assoc. 2006 Nov-Dec;13(6):581-92. doi: 10.1197/jamia.M2142.
Turchin A, Gandhi TK, Coley CM, Shubina M, Broverman C. The use of electronic medication reconciliation to establish the predictors of validity of computerized medication records. Stud Health Technol Inform. 2007;129(Pt 2):1022-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PAMLTIPS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.